Serial changes in pleural lavage cytology during lung cancer surgery predict recurrence and pleural dissemination
Surgery Today · 2025
DOI: 10.1007/s00595-025-03159-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Go Kamimura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8520…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Recurrence, Local, Therapeutic Irrigation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Kagoshima University.
Abstract (Originalsprache)
Purpose
Pleural lavage cytology (PLC) is a recognized prognostic marker in non-small cell lung cancer (NSCLC); however, the impact of serial intraoperative changes remains unclear.
Methods
We retrospectively analyzed 439 patients who underwent curative NSCLC resection. PLC was performed at three intraoperative points: after thoracotomy (pre-PLC), after lung resection, and after lavage at chest closure (post-PLC). Associations between recurrence-free survival (RFS) and pleural dissemination were evaluated by a Kaplan–Meier analysis and Fine and Gray competing risks regression.
Results
Forty-one patients had at least one positive PLC result. RFS was the lowest in pre-PLC( +)/post-PLC( +) ( n = 10), intermediate in pre-PLC(–)/post-PLC( +) ( n = 11), and best in post-PLC( −) ( n = 20). Importantly, post-PLC( −) patients included 13 patients with pre-PLC positivity, yet their RFS matched that of consistently negative cases ( n = 398). The cumulative incidence of pleural dissemination exhibited a similar pattern. In a multivariate analysis, post-PLC positivity, but not pre-PLC positivity, independently predicted poor RFS (hazard ratio, 3.06; p < 0.001).
Conclusion
Post-PLC, but not pre-PLC, provides decisive prognostic information for recurrence and pleural dissemination, likely reflecting residual lavage-resistant tumor clusters. Importantly, combining pre- and post-PLC results refines risk stratification and identifies the poorest-outcome subgroup that may benefit from adjuvant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Thoracic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan. k6474547@kadai.jp.
- Department of General Thoracic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
Förderung
- Japan Agency for Medical Research and Development
- Kagoshima University
Zitieren
APA
Kamimura, G., Aoki, M., Imamura, S., Morizono, S., Nonaka, Y., Tokunaga, T., Harada-Takeda, A., Maeda, K., Nagata, T., & Ueda, K. (2025). Serial changes in pleural lavage cytology during lung cancer surgery predict recurrence and pleural dissemination. Surgery Today. https://doi.org/10.1007/s00595-025-03159-y
Vancouver
Kamimura G, Aoki M, Imamura S, Morizono S, Nonaka Y, Tokunaga T, et al. Serial changes in pleural lavage cytology during lung cancer surgery predict recurrence and pleural dissemination. Surgery Today. 2025. doi:10.1007/s00595-025-03159-y
BibTeX
@article{Kamimura2025,
author = {Kamimura, Go and Aoki, Masaya and Imamura, Satomi and Morizono, Shoichiro and Nonaka, Yuto and Tokunaga, Takuya and Harada-Takeda, Aya and Maeda, Koki and Nagata, Toshiyuki and Ueda, Kazuhiro},
title = {Serial changes in pleural lavage cytology during lung cancer surgery predict recurrence and pleural dissemination},
journal = {Surgery Today},
year = {2025},
doi = {10.1007/s00595-025-03159-y}
}
EUVIMED